期刊文献+

血液净化膜材和抗凝剂对凝血过程中接触活化的影响 被引量:2

Effect of Blood Purification Materials and Anticoagulants on the Contact Activity of Factor ⅩⅡ
下载PDF
导出
摘要 目的 研究五种血液净化膜材即磺化聚醚砜(PES- SO3Na)、聚醚砜(PES)、聚砜(PS)、聚甲基丙烯酸甲酯(PMMA)、醋酸纤维素(CA)活化凝血十二因子(F )的时间动力学,以及三种抗凝剂(肝素、枸橼酸钠、乙二胺四乙酸二钠)对 因子接触活化的影响。方法 采用测定材料结合的F 的活化产物α- F a的促凝活性水平用来评价接触活化的程度。结果 1材料不同活化F 的速度和程度不同;同一材料与不同抗凝剂抗凝血浆孵育,活化F 的程度不同;2不论使用哪种抗凝剂,PES- SO3Na活化F 的程度都是最低的。结论 1五种膜材中,PES-SO3Na表面吸附的血浆F 的活化程度最小,血液相容性最好;2材料表面的F 的接触活化受到抗凝剂的影响。 Objective This study was conducted to examine the degree of contact activation of five blood purification materials sulfonated polyethersulfone (PES-SO_3Na), polyethersulfone (PES), polysulfone (PS), polymethylmethacrylate (PMMA) and cellulose acetate (CA) after they were incubated in anticoagulant-containing human plasma for 10 minutes at 37 ℃. Methods Three anticoagulants Heparin, Trisodium citrate and Disodium EDTA were used. The time course for generation of FⅩⅡ activity by the materials after incubation in anticoagulant-containing human plasma was evaluated. The degree of contact activation was determined by measuring membrane-bound α- FⅩⅡa activity level. Results ①The five materials caused different increase at different rate in the generation of α- FⅩⅡa after they were separately incubated with each of the three anticoagulants. ②PES-SO_3Na activated the least FⅩⅡ no matter which anticoagulant the plasma contained. Conclusion Contact activation can be mediated by antithrombotic agent. PES-SO_3Na has the best blood compatibility with respect to contact activation considering intrinsic coagulation.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2005年第3期411-414,共4页 Journal of Sichuan University(Medical Sciences)
基金 国家"九五"科技攻关项目 (97-5 64 -0 1-0 5 )资助
关键词 接触活化 凝血十二因子 抗凝剂 血液净化 Contact activation Factor ⅩⅡ ( FⅩⅡ) Anticoagulant Blood purification
  • 相关文献

参考文献7

  • 1Matata BM, Courtney JM, Sundaram S, et al. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factorⅫ(FⅫ): Its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes. J Biomed Mater Res,1996;31(1): 63.
  • 2Matata BM, Wark S, Sundaram S, et al. In vitro contact phase activation with hemodialysis membranes: role of pharmaceutical agents. Biomaterials, 1995;16(17):1305.
  • 3Mitropoulos KA, Martin JC, Stirling Y, et al. Activation of factor Ⅻ and Ⅶ induced by citrated plasma in the presence of contact surface. Thrombosis Research,1995;78(1):67.
  • 4Mitropoulos KA. High affinity binding of factor F ⅩⅡ a to an electronegative surface controls the rates of factor ⅩⅡ and prekallikrein activation in vitro. Thrombosis Res,1999;94(2):117.
  • 5Colman RW,Schmaier AH. Contact system: a vascula biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood,1997;90(10):3819.
  • 6Courtney JM, Irvine L, Jones C, et al. Biomaterials in medicine-a bioengineering perspective. Int J Artif Organs,1993;16(3):164.
  • 7Mandenius CF, Ljunggren L. Ellipsometric studies of plasma protein adsorption on membranes polymers for blood purification. Biomaterials,1991;12(4):369.

同被引文献33

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部